Table 3.
ED dose given | Correct (n = 980) | Overdose (n = 318) | Under dose (n = 3143) | p |
---|---|---|---|---|
Age (y), mean(SD) | 53.8 (19.9) | 55.4 (19.8) | 52.8 (17.2) | 0.044 |
Weight (kg), mean (SD)* | 61.6 (10.2) | 48.8 (11.6) | 93.9 (26.3) | <0.001 |
Serum creatinine (mg/dl), median (SD) | 0.83 (1.99) | 0.85 (1.96) | 0.95 (1.99) | 0.005 |
Caucasian race, n (%) | 408 (41.6) | 102 (32.1) | 1405 (44.7) | <0.001 |
Male sex, n (%) | 418 (42.7) | 108 (34.0) | 1822 (58.0) | <0.001 |
Vasopressors in ED, n (%) | 106 (10.8) | 45 (14.1) | 279 (8.9) | 0.008 |
SSTI**, n (%) | 328 (33.5) | 59 (18.6) | 1468 (46.7) | <0.001 |
Pulmonary source, n (%) | 337 (34.4) | 134 (42.1) | 752 (23.9) | <0.001 |
Intra abdominal source, n (%) | 90 (9.2) | 29 (9.1) | 199 (6.3) | 0.006 |
Urinary source, n (%) | 156 (15.9) | 68 (21.4) | 424 (13.5) | 0.012 |
Only significant predictor of dosing accuracy after multivariable comparison
Skin and soft tissue infection